The earnings call reflects a period of transition and mixed results for Rockwell Medical. Despite achieving profitability on an adjusted EBITDA basis and successfully strengthening its contract portfolio, the company faced significant challenges with declining net sales, gross profit, and ongoing customer transition issues. The improved cash position and expansion of the customer base are positive signs, but significant hurdles remain.

Company Guidance

During Rockwell Medical's Third Quarter 2025 Earnings Conference Call, the company reported a profitable quarter on an adjusted EBITDA basis, aligning with its full-year guidance. Net sales were $15.9 million, reflecting a 44% decrease from the previous year due to the transition of their largest customer to another supplier. Despite this, the company maintained an adjusted gross margin within the guidance range of 16-18%. Additionally, Rockwell secured several new long-term contracts, including a significant agreement with a dialysis center in Southern Florida that could generate approximately $1 million in annualized net sales. The company's cash position increased to $23.7 million by the end of Q3, providing opportunities for further investments and business development. Despite the decrease in revenue, the company remains optimistic about its growth trajectory, supported by a strengthened contract portfolio and ongoing discussions with potential new customers.

Profitability Achieved on Adjusted EBITDA Basis

Rockwell Medical was profitable on an adjusted EBITDA basis for the third quarter of 2025, continuing to track in line with full year guidance and showing improvement over previous quarters.

Successful Contract Portfolio Strengthening

Over 80% of Rockwell Medical's customers are now operating under long-term agreements, providing stability and revenue visibility for the company.

Expansion of Customer Base

Rockwell Medical signed several new long-term product purchasing agreements, including a 3-year commitment with a dialysis center in Southern Florida and an expanded agreement with the largest provider of dialysis and skilled nursing facilities in the U.S.

Improved Cash Position

Cash, cash equivalents, and investments available for sale increased to $23.7 million as of September 30, 2025, from $18.4 million at the end of Q2 2025.

Rockwell Med (RMTI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

RMTI Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Mar 26, 2026	2025 (Q4)	-0.04 / -	-0.02	―	―	―
Nov 12, 2025	2025 (Q3)	-0.04 / -0.05	0.05	-200.00% (-0.10)	―
Aug 14, 2025	2025 (Q2)	-0.05 / -0.05	0.01	-600.00% (-0.06)	―
May 12, 2025	2025 (Q1)	-0.05 / -0.04	-0.06	33.33% (+0.02)	―
Mar 20, 2025	2024 (Q4)	<0.01 / -0.02	-0.05	60.00% (+0.03)	―
Nov 12, 2024	2024 (Q3)	0.01 / 0.05	-0.07	171.43% (+0.12)	―
Aug 08, 2024	2024 (Q2)	-0.04 / 0.01	-0.18	105.56% (+0.19)	―
May 14, 2024	2024 (Q1)	-0.04 / -0.06	-0.1	40.00% (+0.04)	―
Mar 21, 2024	2023 (Q4)	-0.07 / -0.05	-0.2	75.00% (+0.15)	―
Nov 14, 2023	2023 (Q3)	-0.10 / -0.07	-0.4	82.50% (+0.33)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

RMTI Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 12, 2025	$1.05	$0.96	-8.57%
Aug 14, 2025	$1.04	$1.05	+0.96%
May 12, 2025	$1.12	$1.04	-7.14%
Mar 20, 2025	$1.76	$1.40	-20.45%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Rockwell Medical Technologies (RMTI) report earnings?

Rockwell Medical Technologies (RMTI) is schdueled to report earning on Mar 26, 2026, After Close (Confirmed).

What is Rockwell Medical Technologies (RMTI) earnings time?

Rockwell Medical Technologies (RMTI) earnings time is at Mar 26, 2026, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is RMTI EPS forecast?

RMTI EPS forecast for the fiscal quarter 2025 (Q4) is -0.04.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing